NCT05277571 · Interventional trial
A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)
Overall registry status Completed
Phase 1 · Phase 2
Conditions Atopic Dermatitis
Delaware Valley sites
- Up0110 119 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory